COMMENTARY - THE STRATEGY AND VALUE OF NEUROLEPTIC DRUG-MONITORING

被引:44
作者
CURRY, SH
机构
关键词
D O I
10.1097/00004714-198510000-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:263 / 271
页数:9
相关论文
共 56 条
[1]  
ADAMSON L, 1973, DIS NERV SYST, V34, P181
[2]   PLASMA-LEVELS AND CLINICAL EFFECTS OF THIORIDAZINE AND THIOTHIXENE [J].
BERGLING, R ;
MJORNDAL, T ;
ORELAND, L ;
RAPP, W ;
WOLD, S .
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (2-3) :178-186
[3]   QUANTITATIVE STUDIES OF URINARY EXCRETION OF CHLORPROMAZINE METABOLITES IN CHRONICALLY-DOSED PSYCHIATRIC PATIENTS [J].
BOLT, AG ;
FORREST, IS ;
SERRA, MT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (11) :1205-&
[4]   PHYSICOCHEMICAL AND BIOCHEMICAL ASPECTS OF PHARMACOLOGY [J].
BRODIE, BB .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (07) :600-+
[5]   NEUROLEPTIC BLOOD-LEVELS AND THERAPEUTIC EFFECT [J].
COHEN, BM ;
LIPINSKI, JF ;
POPE, HG ;
HARRIS, PQ ;
ALTESMAN, RI .
PSYCHOPHARMACOLOGY, 1980, 70 (02) :191-193
[6]  
COHEN BM, 1984, GUIDELINES USE PSYCH
[7]  
COHEN BM, 1980, PSYCHIAT RES, V1, P173
[8]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS [J].
COOPER, TB .
CLINICAL PHARMACOKINETICS, 1978, 3 (01) :14-38
[9]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[10]   SIMPLE AND SENSITIVE RADIORECEPTOR ASSAY FOR ANTI-SCHIZOPHRENIC DRUGS IN BLOOD [J].
CREESE, I ;
SNYDER, SH .
NATURE, 1977, 270 (5633) :180-182